176 related articles for article (PubMed ID: 36634204)
1. The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression.
Hong YG; Yang Z; Chen Y; Liu T; Zheng Y; Zhou C; Wu GC; Chen Y; Xia J; Wen R; Liu W; Zhao Y; Chen J; Gao X; Chen Z
Cancer Res; 2023 Mar; 83(6):845-860. PubMed ID: 36634204
[TBL] [Abstract][Full Text] [Related]
2. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.
Zhang N; Shen Y; Li H; Chen Y; Zhang P; Lou S; Deng J
Exp Mol Med; 2022 Feb; 54(2):194-205. PubMed ID: 35217832
[TBL] [Abstract][Full Text] [Related]
3. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.
Li Q; Ni Y; Zhang L; Jiang R; Xu J; Yang H; Hu Y; Qiu J; Pu L; Tang J; Wang X
Signal Transduct Target Ther; 2021 Feb; 6(1):76. PubMed ID: 33619246
[TBL] [Abstract][Full Text] [Related]
5. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.
Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W
Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881
[No Abstract] [Full Text] [Related]
6. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
[TBL] [Abstract][Full Text] [Related]
7. RNA m6A reader YTHDF1 facilitates inflammation via enhancing NLRP3 translation.
Hao WY; Lou Y; Hu GY; Qian CY; Liang WR; Zhao J; Wang XH
Biochem Biophys Res Commun; 2022 Aug; 616():76-81. PubMed ID: 35649302
[TBL] [Abstract][Full Text] [Related]
8. RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68.
Nie Q; Wu X; Huang Y; Guo T; Kuang J; Du C
Eur J Med Res; 2023 Dec; 28(1):552. PubMed ID: 38042806
[TBL] [Abstract][Full Text] [Related]
9. N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.
Zhang X; Su T; Wu Y; Cai Y; Wang L; Liang C; Zhou L; Wang S; Li XX; Peng S; Kuang M; Yu J; Xu L
Cancer Res; 2024 Mar; 84(6):827-840. PubMed ID: 38241695
[TBL] [Abstract][Full Text] [Related]
10. YTHDF1 promotes gallbladder cancer progression via post-transcriptional regulation of the m6A/UHRF1 axis.
Chen J; Bai X; Zhang W; Yan Z; Liu Y; Zhou S; Wu X; He X; Yang A
J Cell Mol Med; 2024 May; 28(9):e18328. PubMed ID: 38683130
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses.
Terajima H; Lu M; Zhang L; Cui Q; Shi Y; Li J; He C
PLoS Biol; 2021 Jul; 19(7):e3001292. PubMed ID: 34324489
[TBL] [Abstract][Full Text] [Related]
12. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
[TBL] [Abstract][Full Text] [Related]
13. Sevoflurane impairs m6A-mediated mRNA translation and leads to fine motor and cognitive deficits.
Zhang L; Cheng Y; Xue Z; Li J; Wu N; Yan J; Wang J; Wang C; Chen W; Zhou T; Qiu Z; Jiang H
Cell Biol Toxicol; 2022 Apr; 38(2):347-369. PubMed ID: 33928466
[TBL] [Abstract][Full Text] [Related]
14. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
Dou X; Wang Z; Lu W; Miao L; Zhao Y
BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
[TBL] [Abstract][Full Text] [Related]
15. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.
Chen H; Yu Y; Yang M; Huang H; Ma S; Hu J; Xi Z; Guo H; Yao G; Yang L; Huang X; Zhang F; Tan G; Wu H; Zheng W; Li L
Cell Biosci; 2022 Feb; 12(1):19. PubMed ID: 35197112
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing of HOXB-AS3 underlie the promoting effect of nuclear m6A reader YTHDC1 on the self-renewal of leukemic stem cells in acute myeloid leukemia.
Wu C; Cui J; Huo Y; Shi L; Wang C
Int J Biol Macromol; 2023 May; 237():123990. PubMed ID: 36906205
[TBL] [Abstract][Full Text] [Related]
17. YTHDF1 Enhances Chondrogenic Differentiation by Activating the Wnt/β-Catenin Signaling Pathway.
Yang X; Lin Y; Chen T; Hu W; Li P; Qiu X; Yang B; Liang A; Gao W
Stem Cells Dev; 2023 Mar; 32(5-6):115-130. PubMed ID: 36647682
[TBL] [Abstract][Full Text] [Related]
18. The N6-methyladenosine RNA modification in acute myeloid leukemia.
Yankova E; Aspris D; Tzelepis K
Curr Opin Hematol; 2021 Mar; 28(2):80-85. PubMed ID: 33337619
[TBL] [Abstract][Full Text] [Related]
19. RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.
Fan J; Zhuang M; Fan W; Hou M
PeerJ; 2023; 11():e15706. PubMed ID: 37663284
[TBL] [Abstract][Full Text] [Related]
20. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L
J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]